Daniel E. Lowther

1.7k total citations
15 papers, 850 citations indexed

About

Daniel E. Lowther is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Daniel E. Lowther has authored 15 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 3 papers in Hematology. Recurrent topics in Daniel E. Lowther's work include Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Daniel E. Lowther is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Daniel E. Lowther collaborates with scholars based in United States, United Kingdom and Canada. Daniel E. Lowther's co-authors include David A. Hafler, Amanda Hernandez, Donald M. Rodriguez, Songyan Deng, Nalini Vudattu, Vijay K. Kuchroo, Alexandra Kitz, Markus Kleinewietfeld, Chuan Wu and Kevan C. Herold and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Daniel E. Lowther

13 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Lowther United States 10 426 246 142 130 127 15 850
Songyan Deng United States 19 554 1.3× 154 0.6× 195 1.4× 125 1.0× 84 0.7× 24 1.3k
Gianni Binotto Italy 11 237 0.6× 220 0.9× 184 1.3× 42 0.3× 57 0.4× 34 789
Reiner K. Mailer Germany 19 467 1.1× 78 0.3× 243 1.7× 65 0.5× 99 0.8× 32 996
Gabriella Misiano Italy 14 252 0.6× 59 0.2× 176 1.2× 48 0.4× 156 1.2× 31 766
Myoungsun Son United States 18 675 1.6× 124 0.5× 293 2.1× 28 0.2× 64 0.5× 25 1.1k
Pia Svendsen Denmark 16 397 0.9× 135 0.5× 263 1.9× 22 0.2× 154 1.2× 30 1.1k
Suzhao Li United States 15 788 1.8× 192 0.8× 490 3.5× 51 0.4× 203 1.6× 32 1.4k
Steven Pfau United States 14 490 1.2× 129 0.5× 276 1.9× 30 0.2× 165 1.3× 31 1.1k
Nobuo Koike United States 13 310 0.7× 161 0.7× 144 1.0× 30 0.2× 53 0.4× 23 827
Isabelle Allaeys Canada 17 294 0.7× 182 0.7× 537 3.8× 40 0.3× 90 0.7× 32 1.2k

Countries citing papers authored by Daniel E. Lowther

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Lowther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Lowther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Lowther more than expected).

Fields of papers citing papers by Daniel E. Lowther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Lowther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Lowther. The network helps show where Daniel E. Lowther may publish in the future.

Co-authorship network of co-authors of Daniel E. Lowther

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Lowther. A scholar is included among the top collaborators of Daniel E. Lowther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Lowther. Daniel E. Lowther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Musa, Hassan Hussein, Michał Mielnik, Suzanne Trudel, et al.. (2025). Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma. Haematologica. 111(2). 665–678.
2.
3.
4.
Stadtmauer, Edward A., Thomas Faitg, Daniel E. Lowther, et al.. (2019). Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma. Blood Advances. 3(13). 2022–2034. 69 indexed citations
5.
Goods, Brittany A., Amanda Hernandez, Daniel E. Lowther, et al.. (2017). Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme. PLoS ONE. 12(9). e0181538–e0181538. 39 indexed citations
6.
Lowther, Daniel E., Brittany A. Goods, Liliana E. Lucca, et al.. (2016). PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight. 1(5). 185 indexed citations
7.
Lowther, Daniel E., Sriram Ramanan, Calvin Park, et al.. (2015). The TIGIT/CD226/CD155 axis is differentially expressed in MS and glioblastoma: implications for autoimmunity and tumor immune escape. (P4.043). Neurology. 84(14_supplement). 2 indexed citations
8.
Lowther, Daniel E., Kent J. Weinhold, Elizabeth A. Reap, et al.. (2015). CBM-06IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB ± IPILIMUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143. Neuro-Oncology. 17(suppl 5). v70.2–v70.
9.
Hernandez, Amanda, Alexandra Kitz, Chuan Wu, et al.. (2015). Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. Journal of Clinical Investigation. 125(11). 4212–4222. 266 indexed citations
10.
Fang, Liangjuan, Daniel E. Lowther, Matthew L. Meizlish, et al.. (2013). The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells. Neuro-Oncology. 15(11). 1479–1490. 70 indexed citations
11.
Lowther, Daniel E., Stephanie Ascough, Anna Ettorre, et al.. (2013). Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response. Acta Neuropathologica. 126(4). 501–515. 31 indexed citations
12.
Lowther, Daniel E. & David A. Hafler. (2012). Regulatory T cells in the central nervous system. Immunological Reviews. 248(1). 156–169. 102 indexed citations
13.
Ingram, Rebecca J., et al.. (2012). The nature of innate and adaptive interleukin‐17A responses in sham or bacterial inoculation. Immunology. 136(3). 325–333. 9 indexed citations
14.
Ingram, Rebecca J., Jeremy D. Isaacs, Gurman Kaur, et al.. (2009). A role of cellular prion protein in programming T‐cell cytokine responses in disease. The FASEB Journal. 23(6). 1672–1684. 20 indexed citations
15.
Bassendine, Margaret F., et al.. (2008). Characterization of hepatitis C RNA-containing particles from human liver by density and size. Journal of General Virology. 89(10). 2507–2517. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Songyan Deng Breakdown of academic impact, for papers by Gianni Binotto Breakdown of academic impact, for papers by Reiner K. Mailer Breakdown of academic impact, for papers by Gabriella Misiano Breakdown of academic impact, for papers by Myoungsun Son Breakdown of academic impact, for papers by Pia Svendsen Breakdown of academic impact, for papers by Suzhao Li Breakdown of academic impact, for papers by Steven Pfau Breakdown of academic impact, for papers by Nobuo Koike Breakdown of academic impact, for papers by Isabelle Allaeys
Rankless by CCL
2026